At-Scale LVV Production
Scaling From Cell Factory™ Systems to an iCELLis® 500 Bioreactor without Affecting Critical Quality Attributes
The Challenge —Evolving from the well-established GMP 48L Nunc™ Cell Factory™ (CF) process, identify an effective, replicable, and large-scale lentiviral vector (LVV) manufacturing process to meet the growing manufacturing demand – especially for market application – without affecting critical quality attributes.